WallStreetZenWallStreetZen

NASDAQ: ENLV
Enlivex Therapeutics Ltd Stock

$1.36-0.02 (-1.45%)
Updated Jul 19, 2024
ENLV Price
$1.36
Fair Value Price
-$0.01
Market Cap
$25.49M
52 Week Low
$1.15
52 Week High
$4.59
P/E
-0.97x
P/B
0.95x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$25.99M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.16
Operating Cash Flow
-$22M
Beta
0.55
Next Earnings
Sep 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ENLV Overview

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ENLV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ENLV ($1.36) is overvalued by 23,843.8% relative to our estimate of its Fair Value price of -$0.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ENLV ($1.36) is not significantly undervalued (23,843.8%) relative to our estimate of its Fair Value price of -$0.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ENLV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ENLV due diligence checks available for Premium users.

Be the first to know about important ENLV news, forecast changes, insider trades & much more!

ENLV News

Valuation

ENLV fair value

Fair Value of ENLV stock based on Discounted Cash Flow (DCF)
Price
$1.36
Fair Value
-$0.01
Undervalued by
23,931.41%
ENLV ($1.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ENLV ($1.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ENLV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ENLV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.97x
Industry
-18.27x
Market
29.62x

ENLV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.95x
Industry
6.22x
ENLV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ENLV's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.1M
Profit Margin
0%
ENLV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$31.0M
Liabilities
$4.2M
Debt to equity
0.16
ENLV's short-term assets ($28.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENLV's short-term assets ($28.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENLV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ENLV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.5M
Investing
$5.1M
Financing
$524.0k
ENLV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ENLV vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ENLV$25.49M-1.81%-0.97x0.95x
NNVC$25.05M+8.16%-2.59x2.35x
NRXP$24.93M0.00%-0.74x-1.65x
SABS$26.21M-0.35%-0.42x0.50x
UBX$24.34M-1.36%-0.64x1.01x

Enlivex Therapeutics Stock FAQ

What is Enlivex Therapeutics's quote symbol?

(NASDAQ: ENLV) Enlivex Therapeutics trades on the NASDAQ under the ticker symbol ENLV. Enlivex Therapeutics stock quotes can also be displayed as NASDAQ: ENLV.

If you're new to stock investing, here's how to buy Enlivex Therapeutics stock.

What is the 52 week high and low for Enlivex Therapeutics (NASDAQ: ENLV)?

(NASDAQ: ENLV) Enlivex Therapeutics's 52-week high was $4.59, and its 52-week low was $1.15. It is currently -70.48% from its 52-week high and 17.83% from its 52-week low.

How much is Enlivex Therapeutics stock worth today?

(NASDAQ: ENLV) Enlivex Therapeutics currently has 18,811,781 outstanding shares. With Enlivex Therapeutics stock trading at $1.36 per share, the total value of Enlivex Therapeutics stock (market capitalization) is $25.49M.

Enlivex Therapeutics stock was originally listed at a price of $336.00 in Jul 31, 2014. If you had invested in Enlivex Therapeutics stock at $336.00, your return over the last 9 years would have been -99.6%, for an annualized return of -45.81% (not including any dividends or dividend reinvestments).

How much is Enlivex Therapeutics's stock price per share?

(NASDAQ: ENLV) Enlivex Therapeutics stock price per share is $1.36 today (as of Jul 19, 2024).

What is Enlivex Therapeutics's Market Cap?

(NASDAQ: ENLV) Enlivex Therapeutics's market cap is $25.49M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enlivex Therapeutics's market cap is calculated by multiplying ENLV's current stock price of $1.36 by ENLV's total outstanding shares of 18,811,781.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.